PharmaVoice

JUNE 15, 2022

Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.

264

264

IDStewardship

JUNE 12, 2022

In this post an infectious diseases pharmacist identifies and discusses 5 things learned from #ASMicrobe 2022 – through Twitter. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 13 June 2022. There are many scientific meetings to go to these days. For infectious diseases enthusiasts, just a few that come to mind include IDweek, ECCMID, ASMicrobe, ACCP, and MAD-ID.

Vaccines 130

Vaccines 130

PharmExec

JUNE 16, 2022

Recent increases in employee burnout and turnover must be addressed.

122

122

pharmaphorum

JUNE 16, 2022

The litany of failed trials of amyloid-targeting drugs for Alzheimer’s disease has added another verse, as Roche concedes that its crenezumab candidate was unable to slow cognitive decline in patients with an inherited form of the disease. The result isn’t a big surprise – Roche terminated two phase 3 trials of crenezumab in people with prodromal to mild sporadic Alzheimer’s in early 2019 after interim analyses found it would be futile to continue – but is another blow to the

Immunization 111

Immunization 111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

JUNE 16, 2022

An effective treatment for psychiatric disorders such as schizophrenia might require a holistic approach to avoid serious side effects, says CEO Steve Paul.

246

246

Outsourcing Pharma

JUNE 14, 2022

During BIO International, US leaders shared lessons learned from COVID-19, and how government and industry are collaborating to avoid future supply chain crises.

104

104

pharmaphorum

JUNE 17, 2022

It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing who are also at high risk for progression to severe COVID-19.” . At the time of authorisation, the United States federal government had already purchased 10 million doses of the drug.

Hospitals 105

Hospitals FDA Vaccines Packaging 105

Pharma Times

JUNE 17, 2022

Verzenios in combination with endocrine treats people with early breast cancer who are at high-risk of recurrence

54

54

Outsourcing Pharma

JUNE 14, 2022

The company has completed its early-phase development and manufacturing facility in Bend, giving it 11 processing suites focused on first steps into the clinic.

74

74

PharmExec

JUNE 14, 2022

Industry must continue research and development to combat the pandemic.

114

114

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JUNE 16, 2022

When creating engagement plans for individual Digital Key Opinion Leaders (DOLs), it’s best to look at a range of data-led metrics about each DOL to fine tune the engagement and maximise benefit for all parties. The simplest, and often easiest metrics to obtain, relate to the activity characteristics of the Digital KOL. In Twitter for example, this may equate to the DOL’s activity levels, follower numbers, and so on.

105

105

Pharma Times

JUNE 17, 2022

Therapy represents the first STAMP inhibitor for patients with chronic myeloid leukaemia

52

52

Aureus Medical Group

JUNE 17, 2022

One of the exciting perks of travel nursing is the ability to visit amazing cities, parks, and monuments across the country. To help you celebrate Pride this year, we’ve assembled a handful of historic Pride landmarks and memorials across the U.S. that you can visit all year-long. So plan a road trip, a weekend getaway, or hop across town to discover, reflect, and celebrate the history that’s shaped the LGBTQIA+ community.

52

52

PharmExec

JUNE 13, 2022

Makar discusses the significance of AstraZeneca’s diabetes and heart failure drug Forxiga (dapagliflozin) for the treatment of chronic kidney disease (CKD).

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

JUNE 15, 2022

The 2nd NSCLC Drug Development Summit returns for its second year to unite biopharma and academic leaders during an exciting era of personalized medicine. The industry is uniting to address mechanisms of drug resistance, spearhead progress in molecular subtyping and define practice-changing drug sequencing and combinations for the largest solid tumor indication, NSCLC.

Immunization 105

Immunization 105

Pharma Times

JUNE 14, 2022

The three-year project will focus on molecular representations and computational tools

52

52

Aureus Medical Group

JUNE 17, 2022

June 19th has been a day of remembrance and reflection for over 155 years, and in 2021 was officially declared a federal holiday. Juneteenth celebrates the day enslaved Americans first learned that slavery ended, two years after the Emancipation Proclamation was declared in 1863. Communities, schools, and businesses across the country come together to listen, learn, and spread awareness of the past and present issues facing the Black community.

52

52

PharmExec

JUNE 17, 2022

Measure tackles infant formula, cosmetics, and diagnostics—plus drug development and access.

FDA 97

FDA 97

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JUNE 16, 2022

In this episode of the pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business to discuss diversity and equity in clinical trials. They discuss the nitty-gritty of clinical trial diversity – why it’s been so hard to achieve, why it’s important, and how to overcome the specific barriers to inclusion for different underrepresented communities.

105

105

OctariusRx

JUNE 17, 2022

This weekend we celebrate Father’s Day. From the OctariusRx team to all our clients, vendors, friends and family, we wish all fathers and father figures a Happy Father’s Day! Fathers are the first teachers and also our toughest critics. Fathers always inspire us to do better. Hard work has always been hereditary in our house. Thank you, Dad, for showing me that all dreams are within reach when you work hard enough to achieve them.

52

52

Pharmaceutical Commerce

JUNE 17, 2022

New service offering is GMP compliant, with single-use fermentation capacity of up to 300 L.

52

52

PharmExec

JUNE 17, 2022

We may be only at the beginning of outcome-measured, value-based healthcare, but this is a chance for pharma organizations to show their mettle as roles are redefined and definitions of ‘value’ are agreed, says Gérard Klop of Vintura.

78

78

pharmaphorum

JUNE 16, 2022

MorphoSys seemingly inexorable shift into an oncology pure-play has continued with an out-licensing deal for two programmes in the kidney disease and immunology categories to China’s HIBio. The German biotech is handing over rights to CD38-targeted antibody felzartamab for two forms of glomerulonephritis and MOR210, an anti-C5aR1 antibody for autoimmune disorders and some forms of cancer, which are both currently in early-stage clinical testing.

104

104

The Luxe Pharmacist

JUNE 16, 2022

Hi pharmily! Cheers to the beginning of summer and the start of APPE rotations for so many rising P4 pharmacy students! APPEs are such an incredible experience but I know the idea of going on rotations after classroom learning, mixed in with post graduation soul searching and preparation can be a bit daunting. I did a pharmacy school panel the other week actually and these topics came up a ton so I figured I’d round up my biggest tips for a successful APPE year into one convenient post.

Compounding 52

Compounding Patient Care 52

Outsourcing Pharma

JUNE 16, 2022

This monthâs announcements on new products, enhanced technology, partnerships, and more includes Eversana, Thermo Fisher Scientific, and other notable companies.

52

52

PharmExec

JUNE 14, 2022

A roadmap for cohering patient perspectives.

Communication 72

Communication 72

pharmaphorum

JUNE 16, 2022

A personalised, treatment plan for patients with breast cancer is the first digital health product to emerge from a newly-announced partnership between digital health specialist Sidekick and pharma group Eli Lilly. The two companies say the integrated digital therapeutic (DTx) for breast cancer will aim to promote behaviour modifications to improve the wellbeing of breast cancer patients as well as adherence to drug treatment, foe example by managing side effects.

Health Insurance Companies 103

Health Insurance Companies Insurance 103

Board Vitals - Pharmacist

JUNE 15, 2022

Physicians aren’t alone in their continuing education requirements. Nursing continuing education is required in most states to ensure that nurses and nurse practitioners keep their knowledge up to date. What do you need to know about CME for nurses, and how can you fulfill your requirements? . Why Do Nurses Need to Earn Continuing Education? . As the medical industry advances, so must the knowledge nurses have.

52

52

Outsourcing Pharma

JUNE 16, 2022

The Biotechnology Innovation Organization elected the fresh slate of leaders during the BIO International Convention, taking place in San Diego this week.

52

52

PharmExec

JUNE 13, 2022

Eagle tele-rheumatology joins list of more than 15 physician specialties.

72

72

pharmaphorum

JUNE 15, 2022

Boehringer Ingelheim must like what it has seen in its two-year-old R&D collaboration with Trutino Biosciences to develop cytokine therapies – it has just taken an option to buy the company outright. The German pharma group originally teamed up with San Diego-based Trutino on a project to apply its drug discovery and development platform to three undisclosed cytokines, making them safer and potentially more effective as treatments for cancer as they could be administered at higher doses.

Immunization 98

Immunization Vaccines 98

Compounding Pharmacy of America

JUNE 15, 2022

A single bad night’s sleep is common once in a while, but it should not be the norm. If you have a hard time sleeping more than a few times a week, whether that’s getting to sleep or staying asleep, be sure to seek medical help. The post How to Get Better Sleep Throughout the Night appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

NICE

JUNE 15, 2022

By Jeanette Kusel, director of scientific advice, Mark Salmon, programme director of information resrouces and Sarah Byron, interim programme director for devices, diagnostics and digital at NICE. The explosion in digital health products has left NHS commissioners wondering how they can possibly sift out what works and what provides maximum benefit for the service and for patients.

52

52